For stock market speculators, the most coveted stars are the mRNA labs. The market capitalization of the five listed companies focused on mRNA platforms has increased 20-fold in eighteen months, from $15 billion at the end of 2019 to $300 billion last August. BioNTech’s has risen to $50 billion and Moderna’s to $126 billion.
Early results from trials in the late 1990s were encouraging, and the healthcare market was captivated by the potential of the new gene therapy. Laboratories became convinced that the human genome is like the MOT. When the car fails, it is necessary to take it to the garage and replace the damaged genes with others in good working order.
We have already recounted in another entry the havoc that this entailed and its subsequent prohibition. But that could not prevent a good stock market boom. Moderna has already launched an HIV mRNA vaccine in Phase 1 clinical trials, while Sanofi is developing its next flu vaccine using the same technique.biotech companies have become the biggest speculative market of all. – El colectivo de Uno / The Collective of One